SUMMARY This study demonstrates a significant reduction in the number of both total T cells and suppressor T cells identified by monoclonal antibodies in multiple sclerosis patients in acute relapse but not in those in remission. The reduction in the number of suppressor T cells was shown by all three monoclonal antibodies used but was most clearly demonstrated using Leu 2a rather than either OKT 8 or OKT 5. These findings suggest that the choice of monoclonal antibody used in a study of suppressor T cell numbers will influence the results and may help explain the lack of agreement in previous studies.
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Quantitative abnormalities of peripheral blood lymphocytes (PBL) and their subpopulations in patients with multiple sclerosis were originally described in the mid 1970s.' 2 Employing monoclonal antibodies, a reduction in the suppressor/cytotoxic T cell subset was demonstrated in multiple sclerosis patients in acute relapse or with progressive disease.34 This was supported by subsequent serial studies,5 6 though more recent work has yielded conflicting results. '-9 We have studied T lymphocytes and their subsets in multiple sclerosis and in particular the changes in the suppressor T cell subset during acute relapse. All patients in the study had clinically definite multiple sclerosis'0 and factors which might influence the results were standardised. Our 
Results
The total mononuclear cell (MNC) count in patients with multiple sclerosis in relapse or in remission was not significantly different from controls (table) . There was a significant reduction in total T cells identified by Leu 4 in multiple sclerosis patients in relapse (0.83 ± 0.13) compared with healthy con-Suppressor T cell changes in active multiple sclerosis: analysis with three different monoclonal antibodies 1063 The changes observed in active multiple sclerosis may reflect a reduction in the density of this molecule on the cell surface or other conformational changes rather than a change in the size of the suppressor T cell subset. 22 The absence in our study of a simultaneous decrease in the total mononuclear cell count or an increase in the numbers of B cells or monocytes would support this. The consequences of alterations in the expression of the surface glycoprotein used to identify suppressor T cells on the function of these cells remains unknown, particularly since no direct correlation has been found between the apparent number and function of suppressor T cells in individual multiple sclerosis patients. 23 In conclusion, this study demonstrates that the choice of monoclonal antibody used to identify suppressor T cells in patients with multiple sclerosis is another factor which must be considered when undertaking a study of lymphocyte changes in multiple sclerosis. This work was supported by grants from the Multiple Sclerosis Society of Ireland, and The Adelaide Hospital, Dublin.
